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San-Huang-Xie-Xin-Tang (SHXXT), a widely used Chinese herbal formula, consists of rhizomes of Rheum oﬃcinale, roots of
Scutellaria baicalensisandrhizomesofCoptischinesis.Thisstudyinvestigatedthemetabolismandpharmacokineticsofpolyphenols
in SHXXT, including baicalin, baicalein, wogonin, emodin, aloe-emodin, rhein and chrysophanol. The quantitation methods of
SHXXT decoction andrat serum using high performance liquid chromatography were developed and validated in this study. After
oral administration of SHXXT decoction to rats, the parent forms of various constituents and their conjugated metabolites in
serum were determined before and after hydrolysis with β-glucuronidase and sulfatase. The results showed that only free form
of rhein can be quantitated, whereas the parent forms of coptisine, palmatine, berberine, baicalein, wogonin, emodin, aloe-
emodin and chrysophanol were not detected in serum. The glucuronides of baicalein, wogonin, emodin, aloe-emodin, rhein
and chrysophanolwere the predominantforms inbloodstream. In order to evaluate the in vivo antioxidant activity of SHXXT, the
serum metabolite of SHXXT was prepared, characterized and followed by evaluation of the eﬀect on AAPH-induced hemolysis.
The results indicated that metabolites of SHXXT exhibited signiﬁcant free radical scavenging activity. We suggest that biologists
redirect their focus to the bioactivity of the conjugated metabolites of these polyphenols.
1.Introduction
San-Huang-Xie-Xin-Tang (SHXXT) is a popular Chinese
medicine formula, containing Rhei Rhizoma (rhizomes of
Rheum oﬃcinale BAILL; RR), Scutellariae Radix (roots of
Scutellaria baicalensis Georgi; SR) and Coptidis Rhizoma
(rhizomes of Coptis chinesis Franch; CR). Numerous studies
have reported bioactivities of SHXXT including hypotension
[1, 2], gastric protection [3, 4], antioxidant [5]a n da n t i -
inﬂammatory eﬀects [6–8]. The chemical composition of
SHXXT is very complex and the major constituents known
are anthraquinones in RR including emodin, aloe-emodin,
rhein, chrysophanol and their glycosides; ﬂavonoids in
SR including baicalin, baicalein, wogonoside, wogonin and
alkaloids in CR including berberine, palmatine, coptisine
(structures shown in Figure 1). However, the information
concerningbiologicalfatesofvariousconstituentsinSHXXT
remains lacking, which prevents us from better understand-
ing the rational of its clinical implication.
On the basis of recent ﬁndings on the metabolism of
ﬂavonoid polyphenols, it is increasingly recognized that
polyphenol glycosides are subject to hydrolysis in gut lumen,
absorbed as theiraglyconesand thenextensively metabolized
by conjugation reactions [9]. This study investigated the
metabolism and pharmacokinetics of polyphenolic deriva-
tives including anthraquinones, ﬂavonoids and isoquinoline
alkaloids after administration of SHXXT decoction to rats.
For more than two decades, the free radical-mediated
peroxidation of membrane lipid and oxidative damage
of DNA has long been thought to be associated with2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Structures of alkaloids and polyphenols in SHXXT.
a variety of health problems, such as cancer, atherosclerosis,
neurodegenerativediseases and aging. Asan extension ofour
pharmacokinetic study, the serum metabolite of SHXXT in
rats was prepared, characterized and the activity against 2,2 -
azobis(2-amidinopropane hydrochloride) (AAPH)-induced
hemolysis was evaluated.
2.Methods
2.1. Materials and Reagents. RR, SR and CR were purchased
from a Chinese drugstore in Taichung. The origin of the
crude drugs were identiﬁed by microscopic examination by
one of the authors (Y.-C.H.). Voucher specimens were de-
posited in China Medical University. Baicalein (purity 98%),
and wogonin (purity 98%) were supplied by Wako (Osaka,
Japan). Aloe-emodin (purity 95%), rhein (purity 95%),
emodin(purity90%),chrysophanol (purity98%),berberine
(purity 99%), palmatine (purity 97%), coptisine (purity
98%), β-glucosidase, β-glucuronidase (typeB-1 from bovine
liver), sulfatase (type H-1 from Helix pomatia, containing
14 000 unitsg−1 of sulfatase and 498 800 unitsg−1 of β-
glucuronidase) and 2-methlylanthraquinone (purity 95%)Evidence-Based Complementary and Alternative Medicine 3
were purchased from Sigma Chemical Co. (St Louis, MO,
USA).
2.2.Preparation ofSHXXT Decoction. CrudedrugsofRR,SR
and CR (2 : 1 : 1) were weighed and boiled in 20-fold volume
of water and heating was carried out on a gas stove. After
boiling,gentleheatingcontinueduntilthevolumereducedto
<10-fold volume. The mixture was ﬁltered with gauze while
hot and suﬃcient water was added to make 10-fold volume
and frozen at −30◦C for later use.
2.3. Quantitation of Alkaloids, Polyphenols and Related Gly-
cosides in SHXXT Decoction. SHXXT decoction (3.0ml) was
mixedwith7.0mlofmethanolandcentrifuged.Theproperly
diluted supernatant (200μl) was added with 200μlo f2 -
methylanthraquinone solution (10.0μgml −1 in methanol)
as internal standard and 20μl were subjected to high
performance liquid chromatography (HPLC) analysis. The
HPLC apparatus included a pump (LC-10AT, Shimadzu,
Kyoto, Japan), an UV detector (SPD-10AVP, Shimadzu) and
anautomatic injector(Series200Autosampler,Perkin Elmer,
USA). The Cosmosil 5C18-ARII column (4.6 × 250mm,
5μm) was equipped with a guard column (4.6 × 50mm,
5μm) (GL Science Inc., Tokyo, Japan). The mobile phase
consisted of acetonitrile (A) –0.1% phosphoric acid (B) and
programmed as follows: A/B: 23/77 (0–10min), 20/80 (15–
25min), 22/78 (30–45min), 38/62 (50–60min), 70/30 (65–
95min) and 23/77 (100–105min). The ﬂow rate was pro-
grammed as follows: 1.0mlmin−1 (0–68min), 0.2mlmin−1
(68–78min), 1.0mlmin−1 (78–100min). The detection
wavelength was set at 250 nm.
Hydrolysis of 1ml of SHXXT decoction was conducted
by incubating with 1ml of 50 units ml−1 of β-glucosidase
solution (in acetate buﬀer, pH 5) at 37◦C for 3h, fol-
lowed by the addition of suﬃcient water to make 2.0ml.
Then 2.0ml of internal standard solution (10.0μgml −1 2-
methylanthraquinone in methanol) was added and 20μlo f
the mixture was subjected to HPLC analysis. The glycoside
contents of baicalein, wogonin, aloe-emodin, rhein, emodin
and chrysophanol were calculated by subtracting the con-
centrations of each aglycone in the decoction from those of
correspondent aglycone in the hydrolysate.
2.4. Metabolism and Pharmacokinetics of SHXXT in Rats
2.4.1. Animals and Drug Administration. Male Sprague-
Dawley rats were supplied by National Laboratory Animal
Center (Taipei, Taiwan) and housed in a 12-h light–dark
cycle, constant temperature environment prior to study at
the Animal Center of China Medical University (Taichung,
Taiwan). Twelve male Sprague-Dawley rats weighing 320–
450g were fasted for 12 hours before drug administration
and food was withheld for another3h. Ratswere orally given
10mlkg−1 of SHXXT decoction, equivalent to 5gkg−1 of
crude drugs. Water was supplied ad libitum.
2.4.2. Blood Sample Collection. Blood samples (1.0ml) were
withdrawn via cardiac puncture before and at 10, 30, 60,
240, 480, 720, 1440 and 2880min after administration of
SHXXTdecoction.Bloodsamples were centrifuged to obtain
serum, which was stored at −30◦C for later analysis. This
animal study adhered to The Guidebook for the Care and
Use of Laboratory Animals (2002) (Published by The Chinese
Society for the Laboratory Animal Science, Taiwan, ROC).
The Committee of Animal Management in China Medical
University approved the animal study.
2.4.3. Quantitation of Polyphenols and Their Conjugated
Metabolites in Serum. The conjugated metabolites in serum
were determined through hydrolysis with glucuronidase
and sulfatase. Serum (150μl) was mixed with 150μlo fβ-
glucuronidase (2000 units ml−1 in pH 5 acetate buﬀer) or
sulfatase (1000 units ml−1 containing 35 600 units ml−1 of
β-glucuronidase in pH 5 acetate buﬀer), 50μlo fa s c o r b i c
acid (150mgml−1)a n di n c u b a t e da t3 7 ◦C for 4 hours.
After hydrolysis, serum was added with 50μlo f0 . 1 NH C l
and partitioned with 400μl of ethyl acetate (containing
0.125μgml −1 of 2-methylanthraquinone as the internal
standard) and then centrifuged at 10 000g for 15min. The
ethyl acetate layer was evaporated under nitrogen to dryness
and reconstituted with mobile phase for HPLC analysis.
For the determination of free forms of polyphenols,
serum (150μl) was added with 50μl of 0.1NHCl, 150μl
of pH 5 acetate buﬀer, 50μl of ascorbic acid (150mgml−1)
and partitioned with 400μl of ethyl acetate (containing
0.125μgml −1 of 2-methylanthraquinone as the internal
standard). The ethyl acetate layer was concentrated under
nitrogen and reconstituted with mobile phase, then subject
to HPLC analysis. On the other hand, gradient elution using
m i x t u r eo fa c e t o n i t r i l e( A )a n d0 . 1 %p h o s p h o r i ca c i d( B )
as the mobile phase was programmed as follows: A/B: 30/70
(0min); 70/30 (25min), 80/20 (26–30min) and 30/70 (40–
45min). The detection wavelengthwas set at 250 nm and the
ﬂowratewas0.8mlmin−1.The serumstandards ofbaicalein,
aloe-emodin, wogonin, rhein, emodin,chrysophanol were in
the concentration ranges of 0.3–20.0, 0.2–10.0, 0.2–5.0, 0.2–
10.0, 0.2–10.0 and 0.2–5.0μgml −1, respectively.
2.4.4. Validation of the Assay Methods. The system suitability
was evaluated through analysis of precision and accuracy.
The precision was evaluated using intra-day and inter-
day assays of standards three times daily and over three
consecutive days. The accuracy of the system was expressed
by the relative error of the mean calculated concentration to
the real concentration of each calibrator. The recoveries of
each compound from serum were determined by comparing
the peak area of extracted serum standards to the peak area
of unextracted standards spiked in extracted serum. The
LLOQ (lower limit of quantitation) represents the lowest
concentration of analysis in a sample that can be determined
with acceptable precision and accuracy, whereas LOD (limit
of detection) represents the lowest concentration of analysis
in a sample that can be detected (with signal/noise >3).
2.5. Antioxidant Activity of Serum Metabolites of SHXXT
2.5.1. Preparation of Erythrocytes Suspension. Four rats were
fasted for 12 hours, blood was withdrawn via cardiac4 Evidence-Based Complementary and Alternative Medicine
punctureandthencollectedintovacutainertubescontaining
EDTA. After removing plasma and buﬀy coat, erythrocytes
were washed ﬁve times with two volumes of cold phosphate-
buﬀered saline (PBS). During the last wash, the erythrocytes
were centrifuged at 2500g for 10min to obtain a packed cell
preparation. The packed erythrocytes were then suspended
in four volumes of PBS solution.
2.5.2. Preparation and Characterization of Serum Metabolites
of SHXXT. After overnight fast, ﬁve Sprague-Dawley rats
wereadministeredorallywith5.0gkg−1 ofSHXXTdecoction
via gastric gavage. Half an hour later, a second dose was
boosted. At 30min after the second dose, blood was with-
drawn from rats to obtain serum. Four volumes of methanol
was mixed with serum and centrifuged to remove proteins.
The supernatant was evaporated under vacuum to dryness
and the residue was dissolved with water. The aqueous
solutions of metabolites were lyophilized to obtain powders
and stored at −80◦C, of which an aliquot was quantitated
following the procedures described earlier for serum assay.
2.5.3. AAPH-induced Hemolysis Assay. The serum metabo-
lite of SHXXT was reconstituted with PBS to aﬀord 1-,
1/2- and 1/8-fold of serum levels. Besides, blank serum was
collected from rats after overnight fast and processed in
the same manner to prepare a sample of blank serum as
control. To 100μl of erythrocyte suspension, the mixtures
of 100μl of 200mM AAPH (in PBS) and 200μlo fP B S
containingvariousconcentrationsofSHXXTserummetabo-
lites were added. The reaction mixture was shaken gently
and incubated at 37◦C for 0, 1, 2, 3, 4 and 5 hours. After
incubation, the reaction mixture was added with 600μlo f
PBS and centrifuged at 10 000g for 1min. The percentage of
hemolysis was determined by measuring the absorbance at
540 nm and compared with that of complete hemolysis.
2.6. Data Analysis. The peak serum concentration (Cmax)
was recorded as observed. Noncompartment model of WIN-
NONLIN (version 1.1, SCI software, Statistical Consulting
Inc., Apex, NC, USA) was used for the computation of
pharmacokinetic parameters. The area under the serum
concentration-time curve (AUC0−t) was calculated using
trapezoidal rule to the last point. Data for the percentage
of hemolysis of among groups were statistically compared
using ANOVA followed by Scheﬀe’s post hoc test. A level of
probability of ≤0.05 was considered to be signiﬁcant.
3.Results
3.1. Quantitation of Alkaloids, Polyphenols and Related Gly-
cosides in SHXXT Decoction. Figure 2(a) shows the HPLC
chromatogram of SHXXT decoction. Good linear relation-
shipswere obtainedintheconcentrationrangesof3.1–100.0,
3.1–100.0, 15.6–500.0, 12.5–400.0, 7.8–250.0, 0.8–25.0, 3.1–
100.0,3.1–100.0,0.3–10.0and0.3–10.0μgml −1 forcoptisine,
palmatin, berberine, baicalin, baicalein, aloe-emodin, wogo-
nin, rhein, emodin and chrysophanol, respectively. Valida-
tionofthe method indicatedthat thecoeﬃcientsofvariation
Table 1: Contents (mmol) of various constituents in the
hydrolysate of SHXXT (5g) decoction.
Constituents Contents
Coptisine 21.4
Palmatine 16.6
Berberine 60.0
Baicalein 118.8
Aloe-emodin 16.5
Wogonin 32.8
Rhein 49.5
Emodin 9.8
Chrysophanol 2.0
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Figure 2: HPLC chromatograms of SHXXT decoction (a) and its
hydrolysate (b) 1: coptisine, 2: baicalin, 3: palmatine, 4: berberine,
5: baicalein, 6: aloe-emodin, 7: wogonin, 8: rhein, 9: emodin, 10:
chrysophanol, IS: 2-methylanthraquinone.
were <10% and the relative errors were <20% for intra-
day and inter-day analysis. Hydrolysis of SHXXT decoction
using β-glucosidase resulted the chromatogram shown in
Figure 2(b), indicating that the polyphenol peaks were
markedly increased. The contents of various constituents
with relatedglycosidesinthedecoctionwerelistedin Table 1.
The relative abundance of each constituent (aglycone +
glycosides) was as follows: baicalein > berberine > rhein >
wogonin > coptisine > palmatine, aloe-emodin > emodin >
chrysophanol.
3.2. Metabolism and Pharmacokinetics of SHXXT in Rats.
Ourpreliminary studyusing 4-foldmethanoltodeproteinizeEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: HPLC chromatograms of rat serum after administration
of SHXXT. (a) serum specimen before hydrolysis (b) serum
specimen hydrolyzed with β-glucuronidase (c) serum specimen
hydrolyzed with sulfatase/glucuronidase 1: baicalein, 2: aloe-
e m o d i n ,3 :w o g o n i n ,4 :r h e i n ,5 :e m o d i n ,6 :c h r y s o p h a n o l ,I S :2 -
methylanthraquinone.
the serum revealed the absence of berberine, palmatine and
coptisine. Typical HPLC chromatograms of serum sample
before and after treatments with glucuronidase and sulfatase
are shown in Figure 3, indicating that besides rhein, the
parent forms of baicalein, wogonin, emodin, aloe-emodin
and chrysophanol were not present in serum. However, after
treatments with glucuronidase and sulfatase, the peaks of
baicalein, wogonin, emodin, aloe-emodin and chrysophanol
emerged and the peak of rhein was signiﬁcantly enhanced, a
clear indication that the major molecules in the bloodstream
were their conjugated metabolites. Good linearities were
shown in the ranges of 0.3–20.0μgml −1 for baicalein, 0.2–
5.0μgml −1 for wogonin, 0.2–10.0μgml −1 for emodin, aloe-
emodin and rhein and 0.1–5.0μgml −1 for chrysophanol
in serum. Validation of the method indicated that the
coeﬃcients of variation were less than 10% and the relative
errors were <20% for intra-day and inter-day analysis. The
recoveries of each compound from serum were satisfactory.
Figure 4 depicts the mean serum concentration-time
proﬁlesofvariousconstituentsandtheirconjugatedmetabo-
lites in rats after administration of SHXXT. The pharma-
cokinetic parameters are listed in Table 2. Of ﬂavonoids,
the Cmax and AUC0−t of baicalein glucuronides/sulfates were
higher than those of wogonin glucuronides/sulfates. Among
anthraquinones, the Cmax and AUC0−t of rhein and its
sulfates/glucuronides were higher than others, whereas those
of chrysophanol sulfates/glucuronides were the lowest. The
relative systemic exposure ofeach polyphenolwith theircon-
jugated metabolites was ranked as follows: rhein > baicalein
> emodin > wogonin > aloe-emodin > chrysophanol. The
residence times of the conjugated metabolites of various
polyphenols were quite long except aloe-emodin.
3.3. Inhibition of Serum Metabolites of SHXXT on AAPH-
Induced Hemolysis. The serum metabolites of SHXXT used
for measuring antioxidant activity have been characterized
and the result is shown in Table 3. During incubation with
erythrocytesandAAPHfor5hours,theeﬀectsof1-,1/2-and
1/8-fold of SHXXT blood concentrations against hemolysis
are shown in Figure 5. The serum metabolites of SHXXT at
1- and 1/2-fold of blood level exhibited signiﬁcant free
radical scavenging eﬀect, whereas 1/8-fold was ineﬀective.
4.Discussion
Polyphenols are predominantly present in plants as glyco-
sides. Because authentic compounds of polyphenol glyco-
sides were mostly not available, hydrolysis of SHXXT was
then performed in order to quantitate the total content
of each polyphenol with correspondent glycosides. When
hydrolysis was carried out in 1.2N HCl, serious charring
was observed. Alternatively, β-glucosidase was used for
the hydrolysis and conducted at 37◦C[ 10]. The analytical
methods of SHXXT decoction and serum were developed in
this study and validation of these methods indicated that the
precision and accuracy were satisfactory.
Following oral administration of SHXXT, only rhein
existed in part as free form, whereas the parent forms of
berberine, palmatine, coptisine, baicalein, wogonin, aloe-
emodin, emodin and chrysophanol were not found. The
serum level of rhein, an anthraquinone carboxylic acid, was
rather high, which can be accounted for by the low glu-
curonidation activity of UDP-glucuronyltransferases toward
the class of carboxylic acids [11]. The absence of berberine,
palmatine and coptisine in the blood can be explained by
extensive ﬁrst pass eﬀe c to na c c o u n to ft h a ts e v e r a lm e t a b o -
lites of berberine have been detected in human urine and rat
plasma after intake of berberine [12, 13].The major metabo-
lites identiﬁed in human urine included jatrorrhizine-
3-sulfate, thalifendine-2-sulfate, demethyleneberberine-10-
sulfate and berberrubine [12]. In rat plasma, the free forms
and glucuronides of thalifendine, demethyleneberberine
and jatrorrhizine were identiﬁed [13]. These metabolites
of berberine were formed through dealkylation or/and
conjugation reaction occurring in gut and liver during the
ﬁrst pass. Being salt-like compounds, berberine, palmatine
and coptisine are seemingly too hydrophilic to be absorbed6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Mean (±SE) serum concentration–time proﬁles of sulfates/glucuronides (S/G), glucuronides (G) of various constituents and free
form of rhein after oral administration of SHXXT decoction in nine rats.
throughpassive diﬀusion. Lately,theabsorption ofberberine
was found mediated by organic cationic transporter [14].
In regard to baicalein, wogonin, aloe-emodin, emodin
and chrysophanol, only their conjugated metabolites were
foundinserum,indicatingthattheyweresubjecttoextensive
conjugation metabolism by intestine and liver during the
ﬁrst pass. Since the authentic compounds of the conjugated
metabolites of various polyphenols were not available, their
concentrations in serum were quantitated indirectly through
hydrolysis with glucuronidase and sulfatase. The hydrolysisEvidence-Based Complementary and Alternative Medicine 7
Table 2: Pharmacokinetic parameters of various constituents and their sulfates/glucuronides (S/G) and glucuronides (G) after oral
administrationof SHXXT (5gkg−1)t on i n er a t s .
Constituents Metabolites Cmax (nmolml−1)A U C 0−2880 (nmolminml−1)M R T 0−2880 (min)
Baicalein S/G 5.7 ± 2.8 4733.9 ± 1850.2 920.8 ± 331.9
G5 . 0 ± 2.2 4553.1 ± 2062.2 1081.0 ± 542.2
Wogonin S/G 1.1 ± 0.4 1045.5 ± 491.1 960.7 ± 296.3
G1 . 3 ± 0.8 1479.8 ± 1142.7 1165.0 ± 403.9
Aloe-emodin S/G 3.0 ± 1.3 340.4 ± 176.1 104.4 ± 65.7
G2 . 7 ± 1.4 294.6 ± 165.4 207.8 ± 216.0
Rhein Free form 17.5 ± 4.6 5249.5 ± 3838.8 692.0 ± 293.9
S/G 27.8 ± 15.2 9348.9 ± 5510.3 632.0 ± 226.6
G 22.7 ± 9.0 8736.1 ± 5299.0 779.8 ± 616.4
Emodin S/G 5.0 ± 2.2 1929.4 ± 1012.6 570.9 ± 198.0
G4 . 6 ± 2.0 1221.8 ± 379.3 503.3 ± 388.1
Chrysophanol S/G 0.7 ± 0.3 169.1 ± 79.6 629.4 ± 502.5
G0 . 6 ± 0.3 221.1 ± 209.5 624.3 ± 604.1
Table 3: Contents (μmolml−1) of various constituents in 1-fold
serum level of SHXXT metabolite used for anti-hemolysis test.
Baicalein Aloe-
emodin Rhein Emodin Chrysophanol
Free form ND ND 2.1 ND ND
Sulfates/
glucuronides 1.8 1.3 7.9 0.7 3.9
Glucuronides 1.1 0.2 1.5 0.5 1.3
ND: not detected.
condition has been optimized in our preliminary study. The
optimal durations needed for treatments with glucuronidase
and sulfatase were both 4 hours in the presence of ascorbic
acidandunderanaerobiccondition.Theadditionofascorbic
acid was to avoid the oxidative decay of polypenol aglycones
during the enzymolysis reaction.
Due to considerable amount of glucuronidase in the
sulfatase (type H-1) used in this study, treatment with this
enzyme resulted in the hydrolysis of both sulfates and glucu-
ronides. The results showed that the serum proﬁles of
baicalein, wogonin, rhein, aloe-emodin, emodin and chryso-
phanol liberated by glucuronidase and sulfatase/glucuroni-
dase were comparable, indicating that the glucuronides were
the principal metabolites, whereas their sulfates were neg-
ligible. The mean residence times of the glucu-ronides of
various polyphenols were rather long, indicating possible
enterohepatic recycling of these metabolites. Because the
biotransformations of ﬂavonoids in vivo have been generally
known, the biological fates of anthraquinone polyphenols in
rats is proposed in Figure 6 based on our results.
In the wake of getting the ratios of total AUC0−t
(glucuronides/sulfates + free form) to dose (aglycones +
glycosides) and compared among six polyphenols (data not
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Figure 5: Eﬀects of various serum levels of SHXXT metabolites
on APPH-induced hemolysis. Data are expressed as mean ± SD of
triplicates. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.
shown), the relative bioavailability of polyphenols can be
rankedasfollows: rhein >emodin >baicalein,chrysophanol,
wogonin > a l o e - e m o d i n .T h ef a c tt h a tr h e i ns h o w sp r o -
foundly higher bioavailability than other polyphenols can be
in part accounted for by the underestimated dose, because
rhein can be biotransformed from aloe-emodin [15]a n d
b i a n t h r o n e ss u c ha ss e n n o s i d e sAa n dB[ 16], which had not
beenquantitatedinthisstudy.Inaninvitrostudy,wedidﬁnd
that considerable amount of rhein emerged at once when
sennosides A and B were incubated with feces of rats and
rabbits (data not shown). On the other hand, aloe-emodin8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Biologicalfates of anthraquinonepolyphenols in rats.
was found the least bioavailable, which can be explained by
itspoorsolubilityinvarioussolventanditsinvivoconversion
to rhein [15].
In the AAPH-induced hemolysis assay, our results sug-
gested that the metabolite of SHXXT exhibited promising
free radical scavenging activity compared to blank serum.
The potential protection of erythrocyte membrane from
free-radical attack provides an important pathophysiological
basis for making use of SHXXT as a remedy for free-radical
related diseases such as cancer, atherosclerosis, neurodegen-
erative diseases and aging.
Despite voluminous in vitro bioactivity studies reporting
variousbeneﬁcial eﬀectsofpolyphenols[17–21], ourﬁnding
that virtual absence of the free forms of baicalein, wogonin,
aloe-emodin, emodin and chrysophanol suggests that it is
diﬃcult to infer the in vivo eﬀects of these compounds from
their in vitro activities. In fact, the principle metabolites
in vivo were their glucuronides, which possess completely
diﬀerent physicochemical properties from their free forms.
These metabolites should play more important role for in
vivo activities than their parent forms. It is an important
issue that biologists redirect their targets on the conjugated
metabolites of polyphenols. Several recent studies actually
found the sulfates/glucuronides of morin and quercetin
showed more promising bioactivities than their free forms
[22–24], pointing to the possibility that the conjugated
metabolites of polyphenols were not necessarily inactive and
might be the principal active forms.
5.Conclusion
In SHXXT, alkaloids including berberine, palmatine, copti-
sine and polyphenols except rhein were not absorbed per se.
Glucuronides were the principal metabolites of polyphenols
including baicalein, wogonin, rhein, aloe-emodin, emodin
and chrysophanol. For better understanding the rational
of the clinical implications of polyphenol-rich botanical
products, it is strongly advised that biologists pay more
attention to the bioactivity and toxicity of the metabolites of
these polyphenols.
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